No matches

Educational Resources

ADVENT On Air | Be on the Lookout for EoE: The Importance of Early Diagnosis

Both Clinical and Subclinical Disease Control Are Important to Achieve Disease Modification in AD

Dermatology

5 min

expert video

Both Clinical and Subclinical Disease Control Are Important to Achieve Disease Modification in AD

Type 2 Inflammation

3 min

expert video

Underlying Type 2 Inflammation Drives a Chronic Itch-Scratch Cycle in Atopic Dermatitis

Type 2 Inflammation

3 min

expert video

From Protective Type 2 Immunity to Aberrant Type 2 Inflammation

Which Biomarkers of AD Might Be Robust Enough to Be Evaluated as a Measure of Disease Modification?

Dermatology

4 min

expert video

Which Biomarkers of AD Might Be Robust Enough to Be Evaluated as a Measure of Disease Modification?

Atopic Dermatitis and the Growing Evidence for Its Association with Various Non-Atopic Systemic Diseases

Dermatology

2 min

expert video

Atopic Dermatitis and the Growing Evidence for Its Association with Various Non-Atopic Systemic Diseases

Type 2 Inflammation

2 min

expert video

In Chronic Pruritic Skin Diseases, the Neuroimmune Axis Involves Dynamic Interactions Between Type 2 Inflammation and Sensory Nerves

Itch in Chronic Inflammatory Skin Diseases: Histaminergic and Nonhistaminergic Mechanisms and Role of IL-4 as a Central Orchestrator in Promoting Neuronal Sensitization

Type 2 Inflammation

3 min

expert video

Itch in Chronic Inflammatory Skin Diseases: Histaminergic and Nonhistaminergic Mechanisms and Role of IL-4 as a Central Orchestrator in Promoting Neuronal Sensitization

Type 2 Inflammatory Disease: What Are the Mechanisms that Contribute to the Development of Other Atopic Comorbidities?

Type 2 Inflammation

4 min

expert video

Type 2 Inflammatory Disease: What Are the Mechanisms that Contribute to the Development of Other Atopic Comorbidities?

Coexisting Type 2 Inflammatory Diseases Can Add to the Patient Overall Disease Burden

Type 2 Inflammation

2 min

expert video

Coexisting Type 2 Inflammatory Diseases Can Add to the Patient Overall Disease Burden

Atopic Dermatitis and the Risk of Developing Other Atopic Diseases

Dermatology

3 min

expert video

Atopic Dermatitis and the Risk of Developing Other Atopic Diseases

Atopic and Nonatopic Comorbidities in AD and the Importance of Early Intervention

Dermatology

5 min

expert video

Atopic and Nonatopic Comorbidities in AD and the Importance of Early Intervention

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region